Live Quote · NASDAQIPHAHealthcare· Biotechnology

Innate Pharma S.A.

$0.86▼ 8.14%($-0.08)
MKT CAP $96.44MLAST EARNINGS Sep 17, 2026
50%
Bullish
TickerSpark Score
40/100
▌ Weak
20
Valuation
60
Profitability
45
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPHA research report →

Analyst Price Target
$6.67+672.5% vs. today

Range $4 – $9

Analyst RatingBuy
4 Buy2 Hold0 Sell

Price Chart

-52.56% · this period
$2.54$1.70$0.86Nov 20May 26Nov 20
52-Week Range2% of range
Low
$0.83
Current
$0.86
High
$2.71